Terkko Navigator / European Journal of Cardiovascular Prevention & Rehabilitation

Confronting the reality of COVID

A dialogue between the editor-in-chief and a deputy editor of a cardiology journal during the coronavirus outbreak: Take-home messages from the Italian experience

2019 CORONAVIRUS: What are the implications for cardiology?

Editor’s presentation: Overweight carries a higher risk for developing heart failure

Editor’s presentation: Do we really need biomarkers for cardiovascular risk prediction?

Do we really need more new biomarkers for cardiovascular risk prediction?

Editor’s presentation: Modifiers in cardiovascular risk estimation

Editor’s presentation: Physical activity intensity in coronary patients: Vigorous is better than light, but light is better than nothing

Editor’s Presentation. Secondary prevention: First of all, address the basics

Editor’s Presentation: ‘Preventive Cardiology: Quo vadis?’

Editor’s Presentation: ‘The forbidden fruits: Fake or reality?’

Cardio-diabetology: The new‘sweetheart’ in cardiovascular prevention

The global epidemics of diabetes in the 21st century: Current situation and perspectives

The link between diabetes and atherosclerosis

Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications

The metabolic syndrome– What is it and how should it be managed?

Risk and management of pre-diabetes

Lifestyle factors, self-management and patient empowerment in diabetes care

Targets for blood glucose: What have the trials told us

Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases

Risk factor reduction in type 2 diabetes demands a multifactorial approach

Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease

Heart failure and its complications in patients with diabetes: Mounting evidence for a growing burden

Lower extremity artery disease in patients with type 2 diabetes

Innovations in personalised diabetes care and risk management

Management of patients with type 2 diabetes in cardiovascular rehabilitation

How to reduce risk in secondary prevention: First of all address the basics!

A large Italian cohort on proprotein convertase subtilisin/kexin type 9 inhibitors

Multimodal prehabilitation as a promising strategy for preventing physical deconditioning on the heart transplant waiting list

Anti-inflammatory medications and coronary artery disease

Trends in long-term cardiovascular and renal burdens of the 2017 clinical practice guideline for hypertension in US adults, 1998–2016

Hypertension guidelines in children should be universal

PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemia

A Bayesian meta-analysis on early tobacco exposure and vascular health: From childhood to early adulthood

Acupuncture for stable angina pectoris: A few noteworthy additions

Health literacy in cardiovascular prevention:‘From small things, big things come’

Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?)

Improvement in VO2peak predicts readmissions for cardiovascular disease and mortality in patients undergoing cardiac rehabilitation

Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease

Hospitalizations for cardiovascular diseases attributable to tobacco smoking in France in 2015

The Timed Up and Go test and the ageing heart: findings from a national health screening of 1,084,875 community-dwelling older adults

The emerging role of endothelial function in cardiovascular oncology

Prevalence of familial chylomicronemia syndrome in a quaternary care center

Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism

High-intensity interval training has a greater effect on reverse cholesterol transport elements compared with moderate-intensity continuous training in obese male rats

Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort

Mortality risk comparing walking pace to handgrip strength and a healthy lifestyle: A UK Biobank study

Physical activity pacifies the problematic p66Shc

Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population

Cognitive behavioural therapy for anxiety in cardiovascular diseases and implantable devices: A cautionary note